BP1001

· Bio-Path Holdings, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BP1001, covering 2025-03-07 to 2025-03-07. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML [Phase 2]